A randomized controlled study on the combination of Yushen Yangluan Prescription and acupuncture treatment for patients with kidney deficiency type ovarian reserve dysfunction

开始日期2024-03-01

申办/合作机构

上海市中医医院

ITMCTR2024000249 / RecruitingIIT

A single blind randomized controlled trial: the effect of Yushen Yangluan Prescription combined with acupuncture therapy on kidney deficiency type of ovarian reserve dysfunction

开始日期2024-03-01

申办/合作机构

上海市中医医院

100 项与上海市中医医院相关的临床结果

登录后查看更多信息

0 项与上海市中医医院相关的专利（医药）

登录后查看更多信息

项与上海市中医医院相关的文献（医药）

2023-12-01·Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

[Lipid-lowering effect of drug pair Scutellariae Radix-Coptidis Rhizoma based on lipomics].

Article

作者: Liu, Wang-Zhen-Zu ; Liang, Kun ; Zhang, Jia-Qi ; Hu, Cheng ; Qian, Xiao-Jing ; Wang, Xin-Hong

This study investigated the mechanism of action of Scutellariae Radix-Coptidis Rhizoma(SR-CR) in intervening in non-alcoholic fatty liver disease(NAFLD) in rats based on lipidomics. Thirty-six SD rats were divided into a control group, a model group, SR-CR groups of different doses, and a simvastatin group, with six rats in each group. Rats in the control group were fed on a normal diet, while those in the remaining groups were fed on a high-lipid diet. After four weeks of feeding, drug treatment was carried out and rats were sacrificed after 12 weeks. Serum liver function and lipid indexes were detected using kits, and the pathomorphology of liver tissues was evaluated by hematoxylin-eosin(HE) staining and oil red O staining. Changes in lipid levels in rats were detected using the LC-MS technique. Differential lipid metabolites were screened by multivariate statistical analysis, and lipid metabolic pathways were plotted. The changes in lipid-related protein levels were further verified by Western blot. The results showed that compared with the control group, the model group showed increased levels of alanine aminotransferase(ALT), aspartate aminotransferase(AST), total cholesterol(TC), triglyceride(TG), and low-density lipoprotein cholesterol(LDL-c)(P<0.01), and decreased levels of γ-glutamyl transferase(γ-GT) and high-density lipoprotein cholesterol(HDL-c)(P<0.01), which were significantly recovered by the intervention of SR-CR. HE staining and oil red O staining showed that different doses of SR-CR could reverse the steatosis in the rat liver in a dose-dependent manner. After lipidomics analysis, there were significant differences in lipid metabolism between the model group and the control group, with 54 lipids significantly altered, mainly including glycerolipids, phosphatidylcholine, and sphingolipids. After administration, 44 differential lipids tended to normal levels, which indicated that SR-CR groups of different doses significantly improved the lipid metabolism level in NAFLD rats. Western blot showed that SR-CR significantly decreased TG-synthesis enzyme 1(DGAT1), recombinant lipin 1(LPIN1), fatty acid synthase(FASN), acetyl-CoA carboxylase 1(ACC1), and increased the phosphorylation level of ACC1. These changes significantly decreased the synthesis of TG and increased the rate of its decomposition, which enhanced the level of lipid metabolism in the body and finally achieved the lipid-lowering effect. SR-CR can improve NAFLD by inhibiting the synthesis of fatty acids and TG.

2022-09-01·Phytomedicine

China rheumatoid arthritis registry of patients with Chinese medicine (CERTAIN): Rationale, design, and baseline characteristics of the first 11,764 enrollees

Article

作者: Liu, Wei ; Li, Da ; Huang, Qing-Chun ; Su, Yin ; Jiang, Quan ; Liu, Wei-Xiang ; Song, Meng-Ge ; Tang, Xiao-Po ; Guan, Jin-Zhi ; Li, Ze-Guang ; Liu, Jian ; Su, Xiao ; Wang, Bei ; Wang, Yue ; Gong, Xun ; Liu, Ying ; Zhang, Fu-Yuan ; Tian, Xin-Ping ; Zhu, Wan-Hua ; Fang, Yong-Fei ; He, Dong-Yi ; Wen, Shu-Yun ; Zhang, Chi ; Liu, Ju ; Chang, Tian ; Meng, Qing-Liang ; Peng, Qiu-Wei ; Wei, Shu-Feng ; Jiang, Hong ; Zhang, Jian-Yong ; Hu, Yan ; Xia, Cong-Min ; Yu, Jian-Ping ; Lyu, Ai-Ping ; Li, Hui-Ling ; Peng, Jiang-Yun ; Wang, Hai-Dong ; Zhu, Yue-Lan ; Hou, Xiu-Juan ; Gao, Ming-Li

BACKGROUNDChinese medicine (CM) has become a popular interventional treatment for rheumatoid arthritis (RA). However, limited knowledge about general characteristics and long-term clinical outcomes hampers the development of CM for RA.PURPOSEThe main objectives of the China Rheumatoid Arthritis Registry of Patients with Chinese Medicine (CERTAIN) were to describe the population of RA patients receiving CM treatment in multiple centers in China using different variables and compare these findings with internationally reported data.STUDY DESIGNThe CERTAIN is a prospective, multicenter, observational disease registry.METHODSAdult RA patients who fulfilled the 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for RA and received CM treatment were recruited into the CERTAIN by rheumatologists from 145 hospitals across 30 provinces in China. Data on demographics, disease characteristics, comorbidities, treatments, and adverse events, with a 2-year follow-up, were collected and documented using a predefined protocol.RESULTSIn the 2 years since the study began in September 2019, 11,764 patients have been enrolled (enrolment is ongoing), and 13.10% of participants have completed the 6-month follow-up. We present the baseline characteristics of the first 11,764 enrollees.CONCLUSIONSThe CERTAIN is the first nationwide registry to document comprehensive data on CM treatment in patients with RA. The development of the CERTAIN resource is a significant step forward for Chinese RA patients, herbal medicine users, and research communities and will deepen our understanding of CM for RA.REGISTRATIONThe study was registered at ClinicalTrials.gov (NCT05219214).

2021-10-01·Experimental Cell Research3区 · 医学

Galectin-1 secreted by bone marrow-derived mesenchymal stem cells mediates anti-inflammatory responses in acute airway disease

3区 · 医学

Article

作者: Hou, Jia ; Xu, Jing ; Cai, Feng ; Shi, Kehua ; Ge, Xiahui ; Xiao, Hua ; Chi, Feng ; Bai, Chong ; Fu, Youhui

The hallmarks of allergic airway disease (AAD) include infiltration of inflammatory cells into the bronchoalveolar space. Bone marrow derived mesenchymal stem cells (BMSCs) show anti-inflammatory properties in AAD. In addition, galectin-1 (Gal-1) is a lectin significantly upregulated upon inflammation and is also known to mediate potential anti-inflammatory responses. We hypothesized that BMSCs regulated inflammatory responses by secretion of Gal-1 during AAD pathogenesis. BMSCs were isolated from murine femurs and tibiae and adoptively transferred into an ovalbumin-induced AAD mouse model. Knockdown of Gal-1 in BMSCs was performed using shRNA. Flow cytometry, ELISAs, and immunohistology were performed to analyze inflammatory responses in mice, and a Transwell system was used to establish an in vitro co-culture system of lung epithelial cells (MLE-12) and BMSCs. Administration of BMSCs significantly upregulated Gal-1 expression upon inflammation and decreased infiltration of inflammatory cells and secretion of proinflammatory cytokines in vivo. In addition, we showed that this function was mediated by reduced activation of the MAPK p38 signaling pathway. Similar observations were found using an in vitro lipopolysaccharide-induced model when MLE-12 cells were co-cultured with BMSCs. Gal-1 secretion by BMSCs alleviated inflammatory responses observed in AAD and hence provides a promising therapeutic alternative to AAD patients insensitive to conventional drug treatments.

100 项与上海市中医医院相关的药物交易

登录后查看更多信息

100 项与上海市中医医院相关的转化医学

登录后查看更多信息